Publikationen von 0000-0003-2831-4282
(ORCID: 0000-0003-2831-4282)

Hatzipanagiotou, Maria Eleni , Tannert, Verena, Gerken, Michael, Pigerl, Miriam, Räpple, Sophie, Roth, Jonas, Klinkhammer-Schalke, Monika, Ortmann, Olaf und Seitz, Stephan (2026) Treatment Regimens and Response Rates in Early TNBC: A Review of Real‐World Practice in the Second Decade of the 21st Century. The Breast Journal 2026 (1).

Schweihofer, Verena, Bruss, Christina, Seitz, Stephan, Glehr, Gunther , Hetterich, Madeleine, Weber, Florian , Hatzipanagiotou, Maria Eleni , Fernández-Pacheco Álvarez, Miriam, Ortmann, Olaf , Brockhoff, Gero , Bauer, Richard J. und Wege, Anja Kathrin (2025) Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapy. Cancer Cell International 25, S. 120.

Hatzipanagiotou, Maria Eleni , Pigerl, Miriam, Gerken, Michael, Räpple, Sophie, Zeltner, Verena, Hetterich, Madeleine, Ugocsai, Peter, Inwald, Elisabeth Christine, Klinkhammer-Schalke, Monika, Ortmann, Olaf und Seitz, Stephan (2024) Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer. Breast Cancer Research and Treatment 204, S. 607-615.

Hatzipanagiotou, Maria Eleni , Holzinger, Dana, Millogo, Françoise, Pawlita, Michael und Wacker, Jürgen (2018) Human papillomaviruses in Western Africa: prevalences and risk factors in Burkina Faso. Archives of Gynecology and Obstetrics 298 (4), S. 789-796. Volltext nicht vorhanden.